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Abstract
Background: In 2009, an outbreak of respiratory illness caused by influenza A H1N1 virus occurred worldwide.
Some patients required Intensive Care Unit (ICU) admission. The use of non-invasive ventilation (NIV) in these
patients is controversial, as the aerosol dispersion may contaminate the environment and health-care co-workers.
Methods: Describe the respiratory profile, the mortality rate, and the benefit of using NIV in patients with
confirmed diagnosis of influenza AH1N1 who were admitted in the ICU during the year 2009.
Results: A total of 1, 401 cases of influenza A H1N1 were confirmed in our hospital by real-time RT-PCR in 2009,
and 20 patients were admitted to the ICU. The patients’ ages ranged from 18 to 74 years (median of 42). Acute
Respiratory Failure (ARF) was present in 70% of patients. The median Acute Physiology and Chronic Health
Evaluation II score was 7 (range 7 to 25). Of the 14 patients who developed ARF, 85.7% needed NIV and 14%
needed invasive MV at admission. Our success rate (41.6%) with NIV was higher than that described by others. The
hospital mortality rate was 2.1%. When influenza A H1N1 arrived in Brazil, the disease was already on endemic alert
in other countries. The population was already aware of the symptoms and the health-care system of the
treatment. This allowed patients to be properly and promptly treated for influenza A H1N1, while health-care
workers took protective measures to avoid contamination.
Conclusion: In our study we found a high success and low mortality rates with non-invasive ventilation in patients
with influenza A H1N1.
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Background
In late March of 2009, an outbreak of respiratory illness
caused by swine-origin influenza A H1N1 virus occurred
in Mexico. All patients developed acute respiratory dis-
tress [1], of which 38% died. This pandemic disease
spread quickly throughout the world [1-8].
Some individuals with influenza A H1N1 develop
severe forms of the disease that require hospitalization
in the intensive care unit (ICU), mostly due to acute
respiratory failure (ARF). Different studies have reported
that between 62 and 100% of the patients require
mechanical ventilation (MV), with a mortality rate vary-
ing from16 to 58% [1-5,7-9].
Although frequently used, invasive MV has several
complications, such as ventilator-associated pneumonia,
which is a risk factor for mortality and for diaphrag-
matic dysfunction, which may lead to diaphragm myofi-
ber atrophy [9-11].
Only two studies have addressed the issue of using
noninvasive ventilation (NIV) in patients with influenza
A H1N1 virus, but the controversies regarding its bene-
fit are still unresolved [2,8]. There is a concern that NIV
might lead to aerosol dispersion, which may contami-
nate health-care co-workers [2,8,12]. On the other hand,
NIV prevents the need for endothracheal intubation in * Correspondence: karinatt@einstein.br
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[9,12,13].
In our hospital we had a total of 1, 401 confirmed
cases of influenza A H1N1. In this study we describe
the respiratory profile, the mortality rate, and the benefit
of using NIV in patients with confirmed diagnosis of
influenza AH1N1 who were admitted in the ICU during
the year 2009.
Methods
We retrospectively evaluated the medical charts and
laboratory exams of all influenza A H1N1 virus-sus-
pected patients who were admitted to the ICU during
the year of 2009.
This study was conducted in a 38-bed medical-surgical
ICU of a tertiary-care private hospital in Sao Paulo, Bra-
zil. This is an open-staffing-model ICU where approxi-
mately 2, 200 patients are admitted annually. We have a
nurse:bed ratio of 1:4 in our ICU. This study was
approved by the ethics committee of the Albert Einstein
Jewish Hospital and patient’s consent was waved due to
the study design.
To confirm the cases of swine-origin influenza A
H1N1 virus by real-time RT-PCR (RT-RTPCR), naso-
pharyngeal-swab samples were collected at hospital
admission and respiratory secretions obtained from intu-
bated patients. RT-RTPCR testing was performed in all
patients with suspected signs of influenza A H1N1 that
were treated at our hospital according to published
guidelines from the Center for Disease Control (CDC)
[14,15].
All influenza A H1N1 virus-confirmed patients
admitted to the ICU were included in the study.
We also collected demographic data and information
on coexisting medical conditions, microbiology findings,
incidence of ARF, the requirement of MV (whether
invasive or noninvasive at ICU admission and during
ICU stay), laboratory findings, and gas exchange ratio at
admission (PaO2/FiO2), for each patient. For those
patients who required invasive MV, we evaluated the
need for alveolar recruitment maneuver, MV time, and
MV weaning success. To determine the severity of ill-
ness, the Acute Physiology and Chronic Health Evalua-
tion (APACHE) II score was determined in all patients
within 24 hours of admission in the ICU. We also col-
lected information on the length of the entire hospital
stay (including the time in the ICU) and on mortality
rate.
MV weaning success was considered when the patient
was able to tolerate at least 48 hours without invasive
mechanical ventilation.
Noninvasive mechanical ventilation was instituted in
the confirmed influenza A H1N1 when there were signs
of acute respiratory failure at hospital admission or
during ICU stay. The signs of acute respiratory failure
were tachypnea (respiratory rate higher than 35 rpm),
hypoxemia (PaO2 < 80 mmHg), use of accessory
respiratory muscles, and need of high oxygen concentra-
tion (higher than 40% delivered by simple facial mask or
using mask with a non re-breathing system). NIV suc-
cess was considered when patient was able to improve
oxygenation, respiratory rate (lower than 35 rpm), car-
bon dioxide concentration, the use of accessory respira-
tory muscles within 2 hours of NIV. In case this
improvement was not achieved or patient did not toler-
a t et h eu s eo fN I V ,t h e yw e r ep r o m p t l yi n t u b a t e da n d
assisted with invasive mechanical ventilation. Patients
were informed of the reasons to use NIV to treat acute
respiratory failure, or the need to initiate invasive
mechanical ventilation. Patients needed to collaborate
with NIV to use it, being alert and responsive to com-
mands without agitation.
NIV was delivered by a specific ventilator, BiPap
®
Vision
® (Philips - Respironics) providing a pressure sup-
port ventilation through a total face mask. The respira-
tory therapists were responsible for this therapeutic
intervention. Our ICU has a respiratory therapists:bed
ratio of 1:5.
Patients that were admitted with signs of acute
respiratory failure as described above, with extreme
levels of hypoxemia (PaO2 lower than 60 mmHg with a
high oxygen concentration delivered by a mask with a
non re-breathing system - 100%), low level of conscious-
ness, or refuse to use NIV were promptly intubated at
ICU admission.
MV weaning success was considered when the patient
was able to tolerate at least 48 hours without invasive
mechanical ventilation.
Statistical Analysis
Categorical variables were expressed as absolute and
relative frequencies (percentages). The quantitative vari-
ables were expressed as mean and standard deviation if
normally distributed, or as median and interquartile
range if distributed otherwise. The software R, version
10.1 was used to compute the descriptive statistics [16].
Results
During the year of 2009, we had a total of 4, 308 sus-
pected cases of influenza A H1N1 that were treated in
our hospital. Of these, 1, 401 patients had confirmed
diagnosis of influenza A H1N1 and only 139 of these
patients needed hospital admission. There were 86
patients admitted to the ICU with suspected cases of
swine-origin influenza A H1N1 virus. Of these cases, 20
patients were confirmed with RT-RTPCR test. Our ana-
lyses were based only on the 20 patients with confirmed
influenza A H1N1 that were admitted to the ICU. All
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admitted to our hospital were treated with oseltamivir
within 48 hours of symptoms initiation.
The characteristics of the 20 patients admitted to the
ICU with confirmed cases of influenza A H1N1 virus
are listed in Table 1. The patients’ ages ranged from 18
to 74 years (mean of 42.6 years). Eleven patients (55%)
were male. Ten patients had coexisting medical condi-
tions as follows: asthma (in two patients), diabetes melli-
tus (in three patients, two of whom were also
transplanted patients), coronary insufficiency (in two
patients, one of whom had also chronic obstructive pul-
monary disease), chronic obstructive pulmonary disease
(in one patient), renal transplant (in two patients), liver
transplant (in one patient), and non-Hodgkin’sl y m -
phoma (in one patient).
As shown in Table 2, ARF was present in 14 patients
(70%), due mainly to pneumonia (9 patients, 64.3%) and
also to acute respiratory distress syndrome (ARDS; 5
patients, 35.7%), none of the patients presented acute
hypercapnic respiratory failure. The APACHE II score
ranged from 7 to 25 (median of 7). Gas exchange ratio
(PaO2/FiO2) at hospital admission ranged from 59 to
361 (median, 226.5).
Of the 14 patients who developed ARF, 12 (85.7%)
needed NIV and 2 (14%) needed invasive MV at admis-
sion. The number of days on NIV ranged from 1 to 11
(median of 3 days), being successful in 5 patients
(41.6%; Table 2), none of them had hypercapnic respira-
tory failure. The median carbon dioxide arterial pressure
(PaCO2) before using NIV was 33.8 mmHg (range of 21
to 45 mmHg) and after 2 hours of NIV was 35.8 mmHg
(range of 30 to 43 mmHg). The remaining patients had
to be intubated. We had no ICU health-care co-workers
contaminated by influenza A H1N1 during the study
period, the contamination was monitored by the hospital
infection control department, evaluating all health-care
co-workers that were treating these patients with RT-
RTPCR testing. There were no signs of skin breakdown
with the use of total face mask to deliver NIV and all
these patients cooperated with NIV.
Invasive MV was required in 2 patients at admission
and in 7 after NIV during hospitalization, with a total of
9 patients undergoing invasive MV. Of these 9 patients,
we implemented alveolar recruitment maneuver in 5
patients, but none of them responded successfully, and
8 (88.8%) were successfully weaned from MV. Invasive
MV time ranged from 1 to 12 days (median, 6 days;
Table 2).
ICU length of stay ranged from 1 to 14 days (median,
4 days) and hospital length of stay ranged from 1 to 56
days (median, 10 days). The ICU mortality rate was 15%
(3 patients) and hospital mortality rate was 2.1% for the
confirmed cases of influenza A H1N1 virus.
The 3 patients who died in the ICU had a coexisting
medical condition. One patient had arterial hypertension,
Table 1 Characteristics of the 20 patients with confirmed
cases of swine-origin influenza A H1N1 virus admitted to
the ICU in 2009
Variables Values
Age - years
Mean (95% CI) 42.6 (34.7-50.3)
Male gender - n (%) 11 (55%)
Coexisting condition - n (%)
Asthma 2 (10%)
Diabetes mellitus 3 (15%)
Coronary insufficiency 2 (10%)
Chronic Obstructive Pulmonary Disease (COPD) 1 (5%)
Renal transplant 2 (10%)
Liver transplant 1 (5%)
Non-Hodgkin’s Lymphoma 1 (5%)
95% CI (confidence of interval)
Table 2 Characteristics of the 20 study patients who had
confirmed infection with Novel Swine-Origin Influenza A
(H1N1) Virus admitted to the ICU in 2009
Variables Values
APACHE II score 7 (7-12)
Median (IQR)
Presence of Acute Respiratory Failure (ARF) - n (%) 14 (70%)
Causes of Acute Respiratory Failure (ARF) - n (%)
Acute Respiratory Distress Syndrome (ARDS) 5 (35.7%)
Pneumonia 9 (64.3%)
PaO2/FiO2 ratio
median (IQR) 226.5 (106-
315)
Mechanical Ventilation (MV) on admission - n (%)
No 6 (30%)
Non-Invasive Ventilation (NIV) 12 (60%)
Invasive Mechanical Ventilation (MV) 2 (10%)
Non-Invasive Ventilation (NIV) success rate - n (%) 5 (41.6%)
Invasive Mechanical Ventilation (MV) during ICU -n
(%)
9 (45%)
Mechanical Ventilation (MV) time
Mean (95% CI) 6 days (4.2-9)
Recruitment maneuver - n (%) 5 (55%)
Successful Mechanical Ventilation (MV) weaning rate
- n (%)
8 (88.8%)
ICU length of stay
Median (IQR) 4 days (2-6)
Hospital length of stay
Median (IQR) 10 days (3-
18)
ICU mortality rate - n (%) 3 (15%)
Hospital mortality - n (%) 3 (2.1%)
95% CI (confidence interval); IQR (interquartile range)
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coronary insufficiency.
Discussion
In this study we identified all patients with confirmed
diagnosis of influenza A H1N1 admitted to the Albert
Einstein Jewish Hospital during the year of 2009. We
identified 1, 401 patients with the infection and who
were treated in our hospital. Of these, only 139 (9.9%)
patients needed hospitalization. Of these 139 patients,
20 (14.3%) were admitted to the ICU. Our ICU admis-
sion incidence was lower than that reported in most stu-
dies [3,9]. The exception was a study done in Canada
that reported an even lower incidence (8.1%) [8].
Cases of acute respiratory failure due to influenza A
H1N1 affecting patients younger than the expected age
for patients with seasonal influenza have been previously
reported [1-8]. Our findings are consistent with these
reports.
In regard to the severity of illness, our APACHE II
score (7) was lower than that of other studies, which
reported a median score around 13 to 19 [1,2,8]. Our
APACHE II score was probably lower than other studies
because the disease was already an endemic disease
when it reached Brazil and the population and health-
care co-workers were already alert to the disease signs
and received early treatment. This is probably also the
reason for our low number of patients admitted to the
ICU as reported by other studies.
Similar to other studies, our study identified chronic
lung disease as the most frequent coexisting medical
condition [1-3,5,8,9]. On the other hand, a study by Cao
et al. described arterial hypertension as the most fre-
quent coexisting medical condition [6].
Most of our patients had ARF, as seen in other stu-
dies, with the exception of one study from Japan that
did not report any case of ARF between May and June
of 2009 [1-3,8,9]. In our study, we had 85.7% of the
patients who used NIV at ICU admission to treat
ARF. Our incidence was higher than that of the other
two studies that mentioned the use of NIV at ICU
admission (around 33%) [2,8]. In this study we had a
success rate with NIV in 41.6% of the patients, show-
ing greater success with NIV when compared with the
other two studies (25% in Spain [2] and14.6% in
Canada [8]).
We believe that this difference in NIV success is due
to the disease severity, because our APACHE II score
was lower than that described by others [2,8]. Because
of the low NIV success rate and high endotracheal intu-
bation incidence previously reported in several studies,
many researchers stated that NIV should not be routi-
nely used in patients with pandemic respiratory infec-
tions [1,2,8,17].
Many researchers are concerned about using NIV dur-
ing pandemic respiratory infections due to the infectious
exhaled aerosol that can reach the environment through
the exhalation ports in the NIV mask or tubing, which
may contaminate health-care co-workers [17,18]. For
instance, in a recent study from Australia [9] in which a
significant correlation with the need for invasive MV
and mortality rates was observed (Odds ratio 5.51; 95%
CI 3.95-9.94; p < 0.001), NIV was never considered as
an option.
In the study by Perez-Padilla et al. [1], the authors
reported 22 (11.5%) cases of health-care co-worker con-
tamination with influenza A H1N1, while treating the
first 3 patients who were admitted to the hospital. None
of these patients were undergoing NIV. After an infec-
tion-control measure that enforced patient isolation in
specific hospital areas, use of N95 respirators in addition
t og o g g l e s ,g o w n s ,a n dg l o v e s ,a n dc o n s t a n tu s eo fg e l -
alcohol hand sanitizer, no more health-care co-workers
were contaminated by the disease.
This was not the case in our hospital, where our NIV
success rate was higher than everywhere else, and no
health-care co-worker was contaminated through NIV
and all health-care co-workers used infection control
measures to avoid contamination, such use of goggles,
gowns, gloves, and use of gel-alcohol hand sanitizer. All
influenza A H1N1 ICU patients stayed in individual and
isolated hospital bed, to avoid contamination to other
patients. Our success rate with NIV indicates that
patients with influenza A H1N1 can benefit from it,
thus preventing the need for invasive MV, and minimiz-
ing the incidence of complications such as ventilator-
associated pneumonia [11]. This was the situation
described in Mexico [1], where 4 (22%) patients under-
went invasive MV and had ventilator-associated
pneumonia.
Cheung et al. [17] reported their experience with 20
patients undergoing NIV during severe acute respiratory
syndrome (SARS) in 2003 at a Hong Kong hospital. To
reduce the risk of contamination the staff used a viral/
bacterial filter, N95 respirators, and an oronasal mask to
prevent large leaks through the mouth and exhalation
valve. They were able to prevent endotracheal intubation
in 14 patients (70%) and none of the health-care co-
workers were contaminated. In our hospital all the pro-
tective measures were used to prevent contamination of
health-care co-workers and other ICU patients.
The fact that influenza A H1N1 arrived in Brazil after
being already an endemic alert in other countries pro-
vided the necessary time for the government to set stra-
tegies to control its spread. Additionally, the population
was already aware of the symptoms and the health-care
system of the treatment. This allowed patients to be
properly and promptly treated for influenza A H1N1,
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avoid contamination.
In this scenario, NIV can be safely used in patients
with influenza A H1N1. Nevertheless, the same indica-
tion for using NIV in patients requiring MV for ARF
should be considered for patients with influenza A
H1N1.
In regard to invasive MV, our study had a lower inci-
dence at admission, when compared to other studies
[1-3,8,9]. This can also be related to our low APACHE
II score, as the study by Rello et al. [2] described that
patients who failed NIV had a higher APACHE II score
than those who were successful. Our mechanical ventila-
tion time was lower than that described by others
[1,2,8,9].
In our study 5 patients developed ARDS and were
intubated. Of these patients, all underwent alveolar
recruitment maneuver with high end-expiratory pressure
levels to improve oxygenation, without any related com-
plications. In the studies on influenza A H1N1 patients
currently available [1-9], none mention using this man-
euver to improve oxygenation. In one study, Kumar et
al. [8] reported using inhaled nitric oxide, high fre-
quency oscillatory ventilation, and extracorporeal mem-
brane oxygenation and had 8.3% incidence of
barotraumas.
Regarding the ICU length of stay, our findings were
lower than those reported in previous studies [8,9].
However, in regard to our hospital length of stay, our
findings were similar to those from a study from Austra-
lia [9].
So far, patients with influenza A H1N1 admitted to
hospitals worldwide had a high mortality rate (13 to
39%) [1-9]. However, in our study the hospital mortality
rate was 2.1%. Beside the low APACHE II score of our
patients, it is possible that our low mortality rate is also
associated with a lower number of patients undergoing
invasive mechanical ventilation, as compared to other
studies [1-4,8,9].
Conclusion
In our study we found a high success and low mortality
rates with non-invasive ventilation in patients with influ-
enza A H1N1. Although our study is limited to one cen-
ter only and cannot be representative of the scenario in
Brazil, we had 1, 401 patients with confirmed influenza
A H1N1, of whom most were successfully treated in our
hospital as described.
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